Story perspectives

New Nanobody Antivenom Shows Promise Against 17 Venoms

11/13/2025

50 12

Summary

Story summary

The nanobody-based antivenom shows promise against 17 of 18 tested snake venoms, potentially addressing Africa's 300,000 annual snakebite cases.
Traditional antivenoms often cause allergic reactions and target only a few species.
In laboratory testing, the serum prevented death from 17 of 18 venoms, outperforming existing treatments.
Challenges remain, including high production costs and testing in larger animals, while experts call for manufacturing and regulatory optimization to enable human use.

1 of 1

Story summary

The nanobody-based antivenom shows promise against 17 of 18 tested snake venoms, potentially addressing Africa's 300,000 annual snakebite cases.
Traditional antivenoms often cause allergic reactions and target only a few species.
In laboratory testing, the serum prevented death from 17 of 18 venoms, outperforming existing treatments.
Challenges remain, including high production costs and testing in larger animals, while experts call for manufacturing and regulatory optimization to enable human use.